The Likelihood of Wound Complications Following the Use of Rivaroxaban as a Thrombo-Prophylactic Agent in Patients Undergoing Spinal Canal Stenosis Surgery: A Case Series

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

GOLBAKHSH MOHAMMADREZA; Jamshidof Mohammad; HEYDARI AMIR; Talebiyan Parham; Baghbani Salar; Ebrahimian Mazaher; RASTEGAR MOHAMMAD

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF ORTHOPEDIC AND SPINE TRAUMA Year:2022 | Volume:8 | Issue:4 Page(s): 130-133

Download Full-Text

View:

Download:

Cites:

Information Journal Paper

Title

The Likelihood of Wound Complications Following the Use of Rivaroxaban as a Thrombo-Prophylactic Agent in Patients Undergoing Spinal Canal Stenosis Surgery: A Case Series

Author(s)

Keywords

Cohort Studies

Postoperative Complication

Spine

Surgery

Wounds

Abstract

Background: Wound complications are major morbidities after orthopedic surgery, and thrombo-prophylactic drugs may increase the likelihood of such complications. In this regard, our study has evaluated the possible effects of rivaroxaban on wound complication issues following spinal canal stenosis surgery. Methods: This prospective cohort study was conducted on 40 patients suffering from spinal canal stenosis secondary to degenerative lumbar spine changes. The eligible patients included those patients receiving rivaroxaban to prevent thrombo-emboli post-operatively. The patients were followed up for three months and assessed for postoperative wound-related complications. Results: None of the patients suffered vascular and thromboembolic complications. Regarding wound complications, these events are mostly limited to the first week post-operatively, including wound dehiscence in 5. 0%, serosanguineous discharge in 25. 0%, erythema in 35. 0%, superficial infection in 10. 0%, requiring surgical debridement in 5. 0%, cellulitis in 10. 0%, and wound induration in 30. 0%. Deep infection or hematoma was not reported in our patients. Erythema and wound induration remained 10. 0% and 15. 0% within the second week, respectively. The hypertrophic scar was a delayed complication that appeared in 15. 0% of patients within 1 to 3 months post-operatively. Conclusion: The main risk profiles related to wound complications, especially infections, were a history of hypertension (HTN), uncontrolled diabetes mellitus (DM), and renal insufficiency. The use of rivaroxaban may be accompanied by temporary and minor wound complications and not with potentially debilitating morbidity in patients undergoing spinal canal stenosis surgery. Therefore, its prescription as a safe thrombo-prophylactic drug in patients undergoing spinal canal stenosis surgery is confidently recommended.

Multimedia

No record.

Cites

No record.

References

Cite

APA: Copy

GOLBAKHSH, MOHAMMADREZA, Jamshidof, Mohammad, HEYDARI, AMIR, Talebiyan, Parham, Baghbani, Salar, Ebrahimian, Mazaher, & RASTEGAR, MOHAMMAD. (2022). The Likelihood of Wound Complications Following the Use of Rivaroxaban as a Thrombo-Prophylactic Agent in Patients Undergoing Spinal Canal Stenosis Surgery: A Case Series. JOURNAL OF ORTHOPEDIC AND SPINE TRAUMA, 8(4), 130-133. SID. https://sid.ir/paper/1125120/en

Vancouver: Copy

GOLBAKHSH MOHAMMADREZA, Jamshidof Mohammad, HEYDARI AMIR, Talebiyan Parham, Baghbani Salar, Ebrahimian Mazaher, RASTEGAR MOHAMMAD. The Likelihood of Wound Complications Following the Use of Rivaroxaban as a Thrombo-Prophylactic Agent in Patients Undergoing Spinal Canal Stenosis Surgery: A Case Series. JOURNAL OF ORTHOPEDIC AND SPINE TRAUMA[Internet]. 2022;8(4):130-133. Available from: https://sid.ir/paper/1125120/en

IEEE: Copy

MOHAMMADREZA GOLBAKHSH, Mohammad Jamshidof, AMIR HEYDARI, Parham Talebiyan, Salar Baghbani, Mazaher Ebrahimian, and MOHAMMAD RASTEGAR, “The Likelihood of Wound Complications Following the Use of Rivaroxaban as a Thrombo-Prophylactic Agent in Patients Undergoing Spinal Canal Stenosis Surgery: A Case Series,” JOURNAL OF ORTHOPEDIC AND SPINE TRAUMA, vol. 8, no. 4, pp. 130–133, 2022, [Online]. Available: https://sid.ir/paper/1125120/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops